A novel role for the Rho-associated kinase, ROCK, in IL-1-stimulated intestinal epithelial cell responses

Cellular Immunology

Volumn 280, Issue 2, 2012, Pages 148-155

  Rafferty, Brian J ^a   Unger, Benjamin L ^a   Perey, Aaron C ^a   Tammariello, Steven P ^a   Pavlides, Savvas ^a   McGee, Dennis W ^a  

^a BINGHAMTON UNIVERSITY   (United States)

Author keywords

CCL2; CXCL8; IL 1; Intestinal epithelial; JNK; ROCK

Indexed keywords

I KAPPA B ALPHA; INTERLEUKIN 1; JANUS KINASE; RHO KINASE;

ARTICLE; CYTOKINE RESPONSE; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

CACO-2 CELLS; EPITHELIAL CELLS; HUMANS; INTERLEUKIN-1; INTESTINAL MUCOSA; JNK MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PHOSPHORYLATION; RHO-ASSOCIATED KINASES; SIGNAL TRANSDUCTION;

EID: 84873506034     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2012.12.003     Document Type: Article

References (35)

1. Vincenti M.P., Brinkerhoff C.E. Early response genes induced in chondrocytes stimulated with the inflammatory cytokine interleukin-1β. Arthritis Res. 2001, 3:381-388.
2. Weber A., Wasiliew P., Kracht M. Interleukin-1 (IL-1) pathway. Sci. Signal. 2010, 3:1-6.
3. Jung H.C., Eckmann L., Yang S.-K., Panja A., Fierer J., Morzycka-Wroblewska E., Kagnoff M.F. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J. Clin. Invest. 1995, 95:55-65.
4. McGee D.W., Beagley K.W., Aicher W.K., McGhee J.R. Transforming growth factor-β and IL-1β act in synergy to enhance IL-6 secretion by the intestinal epithelial cell line, IEC-6. J. Immunol. 1993, 151:970-978.
5. Eckmann L., Jung H.C., Schurer-Maly C., Panja A., Morzycka-Wroblewska E., Kagnoff M.F. Differential cytokine expression by human intestinal epithelial cell lines: regulation of interleukin-8. Gastroenterology 1993, 105:1689-1697.
6. Reinecker H.-C., Loh E.Y., Ringler D.J., Mehta A., Rombeau J.L., MacDermott R.P. Monocyte-chemoattractant protein 1 gene expression in intestinal epithelial cells and inflammatory bowel disease. Gastroenterology 1995, 108:40-50.
7. Jobin C., Haskill S., Mayer L., Panja A., Sartor R.B. Evidence for altered regulation of IκBα degradation in human colonic epithelial cells. J. Immunol. 1997, 158:226-234.
8. Jobin C., Sartor R.B. The IκB/NF-κB system: a key determinant of mucosal inflammation and protection. Am. J. Physiol. Cell. Physiol. 2000, 278:C451-C462.
9. Weston C.R., Davis R.J. The JNK signal transduction pathway. Curr. Opin. Cell Biol. 2007, 19:142-149.
10. Mitsuyama K., Suzuki A., Tomiyasu N., Tsuruta O., Kitazaki S., Takeda T., Satoh Y., Bennett B.L., Toyonaga A., Sata M. Pro-inflammatory signaling by Jun-N-terminal kinase in inflammatory bowel disease. Int. J. Mol. Med. 2006, 17:449-455.
11. Roy P.K., Rashid F., Bragg J., Ibdah J.A. Role of the JNK signal transduction pathway in inflammatory bowel disease. World J. Gastroenterol. 2008, 14:200-202.
12. Beaulieu J.-F. Integrins and human intestinal cell functions. Front. Biosci. 1999, 4:d310-d321.
13. Gilcrease M.Z. Integrin signaling in epithelial cells. Cancer Lett. 2006, 247:1-25.
14. Nakagawa O., Fujisawa K., Ishizaki T., Saito Y., Nakao K., Narumiya S. ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice. FEBS Lett. 1996, 392:189-193.
15. Segain J.P., De La Bletiere D.R., Sauzeau V., Bourreille A., Hilaret G., Cario-Toumaniantz C., Pacaud P., Galmiche J.P., Loirand G. Rho kinase blockade prevents inflammation via nuclear factor κB inhibition: evidence in Crohn's disease and experimental colitis. Gastroenterology 2003, 124:1180-1187.
16. Shimizu S., Tahara M., Ogata S., Hashimoto K., Morishige K., Tasaka K., Murata Y. Involvement of nuclear factor-κB activation through RhoA/Rho-kinase pathway in LPS-induced CXCL8 production in human cervical stromal cells. Mol. Hum. Reprod. 2007, 13:181-187.
17. John G.R., Chen L., Rivieccio M.A., Menendez-Vasquez C.V., Hartley A., Brosnan C.F. Interleukin-1β induces a reactive astroglial phenotype via deactivation of the Rho GTPase-Rock axis. J. Neurosci. 2004, 24:2837-2845.
18. Zhou H., Kramer R.H. Integrin engagement differentially modulates epithelial cell motility by RhoA/ROCK and PAK1. J. Biol. Chem. 2005, 280:10624-10635.
19. Li G., Lubin F.D., McGee D.W. α3β1 Integrin induced suppression of the Caco-2 epithelial cell IL-1 signaling pathway leading to NF-κB activation. Cell. Immunol. 2004, 231:30-39.
20. Ishizaki T., Uehata M., Tamechika I., Keel I., Nonomura K., Maekawa M., Narumiya S. Pharmacological properties of Y-27632, a specific inhibitor of Rho-associated kinases. Mol. Pharmacol. 2000, 57:976-983.
21. Davies S.P., Reddy H., Caivano M., Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 2000, 351:95-105.
22. + sensitization. Am. J. Respir. Cell Mol. Biol. 1999, 20:1190-1200.
23. 2-terminal kinase mediates migration of vascular smooth muscle cells stimulated by angiotensin II. Arterioscler. Thromb. Vasc. Biol. 2005, 25:1831-1836.
24. Naydenov N.G., Hopkins A.M., Ivanov A.I. C-Jun N-terminal kinase mediates disassembly of apical junctions in model intestinal epithelia. Cell Cycle 2009, 8:2110-2121.
25. Roebuck K.A. Regulation of interleukin 8 gene expression. J. Interferon Cytokine Res. 1999, 19:429-438.
26. Martin T., Cardarelli P.M., Parry G.C.N., Felts K.A., Cobb E.R. Cytokine induction of monocyte chemochemoattractant protein-1 gene expression in human endothelial cells depends on the cooperative action of NF-kB and AP-1. Eur. J. Immunol. 1997, 27:1091-1097.
27. Yoneda A., Multhaupt H.A.B., Couchman J.R. The Rho kinases I and II regulate different aspects of myosin II activity. J. Cell Biol. 2005, 170:443-454.
28. Arora P.D., Ma J., Min W., Cruz T., McCulloch C.A. Interleukin-1-induced calcium flux in human fibroblasts is mediated through focal adhesions. J. Biol. Chem. 1995, 270:6042-6049.
29. Assi K., Pillai R., Gomez-Munoz A., Owen D., Salh F. The specific JNK inhibitor SP600125 targets tumor necrosis factor-α production and epithelial cell apoptosis in acute murine colitis. Immunology 2006, 118:112-121.
30. Chromik A.M., Müller A.M., Körner J., Belyaev O., Holland-Letz T., Schmitz F., Herdegen T., Uhl W., Mittelkötter U. Genetic deletion of JNK1 and JNK2 aggravates the DSS-induced colitis in mice. J. Invest. Surg. 2007, 20:23-33.
31. Nenci A., Becker C., Wullaert A., Gareus R., van Loo G., Danese S., Huth M., Nikolaev A., Neufert C., Madison B., Gumucio D., Neurath M.F., Pasparakis M. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 2007, 446:557-561.
32. Eckmann L., Nebelsiek T., Fingerle A.A., Dann S.M., Mages J., Lang R., Rovine S., Kagnoff M.F., Schmid R.M., Karin M., Arkan M.C., Greten F.R. Opposing functions of IKKβ during acute and chronic intestinal inflammation. Proc. Natl. Acad. Sci. USA 2008, 105:15058-15063.
33. Egan L.J., de Lecea A., Lehrman E.D., Myhre G.M., Eckmann L., Kagnoff M.F. Nuclear factor-κB activation promotes restitution of wounded intestinal epithelial monolayers. Am. J. Physiol. Cell Physiol. 2003, 285:C1028-C1035.
34. Xavier R.J., Podolsky D.K. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007, 448:427-434.
35. Atreya I., Atreya R., Neurath M.F. NF-κB in inflammatory bowel disease. J. Int. Med. 2008, 263:591-596.